← Leaderboards
Kathleen M Giacomini
University Of California San Francisco
$35,943,104
Attributed
$63,871,776
Total exposure
33
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$69,565,905 · 34
FDA$39,882,208 · 2
By mechanism
U01$69,317,911 · 4
U19$17,033,296 · 2
R01$14,631,205 · 8
UC2$2,896,743 · 1
U24$2,671,899 · 1
R44$1,847,303 · 1
Top collaborators
- Russ Biagio Altman43 shared
- Jose Carlos Florez6 shared
- Monique Marie Hedderson6 shared
- Graham T. Johnson5 shared
- John William Newman4 shared
- Andrew S Greenberg3 shared
- Robert M Stroud3 shared
- Yong Huang2 shared
Others in their field
Top investigators on “Membrane Transport Proteins”
- Robert M Stroud · University Of California, San Francisco$35,155,193
- Mark Donowitz · Johns Hopkins University$24,445,249
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$24,300,554
- Enrique J Rodriguez-Boulan · Weill Medical College Of Cornell Univ$21,773,557
- Robert H Edwards · University Of California, San Francisco$21,006,093
- Peter J Novick · Yale University$19,299,414
Research focus
Membrane Transport ProteinsPharmaceutical PreparationsResponsePlayGenotypeClinical ResearchGeneticPhenotypeResearch PersonnelResourcesVariantGenome-WidePharmacogeneticsGenesCohortAffectBaseSamplingCellsMetforminProgramsGenomicsMediatingKidney
Grant awards (141)
Transporter Elucidation Center at the University of California, San Francisco$968,661
UC2 · FY2025 · HD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$425,000
U01 · FY2025 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$1,257,392
U01 · FY2024 · FD · contact PI
Transporter Elucidation Center at the University of California, San Francisco$959,082
UC2 · FY2024 · HD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$691,776
U01 · FY2024 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$616,363
U01 · FY2024 · FD · contact PI
Characterizing the physiological and pharmacological roles of SLC22A24$463,622
R01 · FY2024 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$425,000
U01 · FY2024 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$350,000
U01 · FY2024 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$350,000
U01 · FY2024 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$250,000
U01 · FY2024 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$240,000
U01 · FY2024 · FD · contact PI
Equipment Supplement NOT-GM-24-021$111,039
R01 · FY2024 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$47,791
U01 · FY2024 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$1,913,010
U01 · FY2023 · FD · contact PI
Transporter Elucidation Center at the University of California, San Francisco$969,000
UC2 · FY2023 · HD
Characterizing the physiological and pharmacological roles of SLC22A24$465,681
R01 · FY2023 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$4,985,961
U01 · FY2022 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$580,000
U01 · FY2022 · FD · contact PI
Characterizing the physiological and pharmacological roles of SLC22A24$499,556
R01 · FY2022 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$435,336
U01 · FY2022 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$245,113
U01 · FY2022 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$200,000
U01 · FY2022 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$155,626
U01 · FY2022 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$43,347
U01 · FY2022 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$6,358,865
U01 · FY2021 · FD · contact PI
Characterizing the physiological and pharmacological roles of SLC22A24$407,602
R01 · FY2021 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$280,055
U01 · FY2021 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$36,586
U01 · FY2021 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$3,071,485
U01 · FY2020 · FD · contact PI
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$624,418
R01 · FY2020 · GM · contact PI
Drug-Vitamin Interactions Mediated by the Thiamine Transporter, SLC19A3$570,643
R01 · FY2020 · DK · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$381,058
U01 · FY2020 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$280,055
U01 · FY2020 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$109,900
U01 · FY2020 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$76,995
U01 · FY2020 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$47,550
U01 · FY2020 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$3,640,082
U01 · FY2019 · FD · contact PI
Drug-Vitamin Interactions Mediated by the Thiamine Transporter, SLC19A3$724,554
R01 · FY2019 · DK · contact PI
PGRN Administrative Coordination Hub, ACH (PGRN)$514,238
U24 · FY2019 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$50,000
U01 · FY2019 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$1,644,668
U01 · FY2018 · FD · contact PI
Discovery of Pharmacogenomic Biomarkers for Metformin Response$720,081
R01 · FY2018 · GM · contact PI
Drug-Vitamin Interactions Mediated by the Thiamine Transporter, SLC19A3$715,283
R01 · FY2018 · DK · contact PI
PGRN Administrative Coordination Hub, ACH (PGRN)$522,571
U24 · FY2018 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$310,000
U01 · FY2018 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$22,010
U01 · FY2018 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$2,536,716
U01 · FY2017 · FD · contact PI
Discovery of Pharmacogenomic Biomarkers for Metformin Response$719,085
R01 · FY2017 · GM · contact PI
Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol$672,937
R01 · FY2017 · DK · contact PI
Drug-Vitamin Interactions Mediated by the Thiamine Transporter, SLC19A3$583,320
R01 · FY2017 · DK · contact PI
PGRN Administrative Coordination Hub, ACH (PGRN)$530,876
U24 · FY2017 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$60,000
U01 · FY2017 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$35,000
U01 · FY2017 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science$2,313,750
U01 · FY2016 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$1,097,504
U01 · FY2016 · FD · contact PI
Discovery of Pharmacogenomic Biomarkers for Metformin Response$803,285
R01 · FY2016 · GM · contact PI
Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol$672,153
R01 · FY2016 · DK · contact PI
PGRN Administrative Coordination Hub, ACH (PGRN)$540,091
U24 · FY2016 · GM · contact PI
Equipment Supplement due 5/20/2016 P0516422$24,942
R01 · FY2016 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$1,100,000
U01 · FY2015 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$1,020,076
U01 · FY2015 · FD · contact PI
Discovery of Pharmacogenomic Biomarkers for Metformin Response$837,363
R01 · FY2015 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$794,575
U01 · FY2015 · FD · contact PI
Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol$671,330
R01 · FY2015 · DK · contact PI
PGRN Administrative Coordination Hub, ACH (PGRN)$564,123
U24 · FY2015 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$237,563
U01 · FY2015 · FD · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$66,000
U01 · FY2015 · FD · contact PI
Pharmacogenomics of Membrane Transporters$3,400,326
U19 · FY2014 · GM · contact PI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation$1,100,000
U01 · FY2014 · FD · contact PI
Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol$647,779
R01 · FY2014 · DK · contact PI
Management$152,700
U19 · FY2014 · GM · contact PI
Project 3$145,543
U54 · FY2014 · GM · contact PI
Pharmacogenomics of Membrane Transporters$3,279,501
U19 · FY2013 · GM · contact PI
Project 3$156,053
U54 · FY2013 · GM · contact PI
Management$149,993
U19 · FY2013 · GM · contact PI
Pharmacogenomics of Membrane Transporters$3,347,599
U19 · FY2012 · GM · contact PI
A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies$923,185
R44 · FY2012 · GM
Project 3$161,713
U54 · FY2012 · GM · contact PI
Management$155,422
U19 · FY2012 · GM · contact PI
Pharmacogenomics of Membrane Transporters$2,818,177
U19 · FY2011 · GM · contact PI
A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies$924,118
R44 · FY2011 · GM
Pharmacogenomics of Membrane Transporters$514,000
U19 · FY2011 · GM · contact PI
Project 3$187,051
U54 · FY2011 · GM · contact PI
Management$159,385
U19 · FY2011 · GM · contact PI
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS$16,768
P41 · FY2011 · RR · contact PI
GENETIC EFFECTS ON TRANSPORTER EXPRESSION IN KIDNEY$10,061
P41 · FY2011 · RR · contact PI
GENETIC RESPONSE OF ANTI-DEPRESSANTS$10,061
P41 · FY2011 · RR · contact PI
GENETIC EFFECTS ON ALLERGIES TO ANTIBIOTICS$10,061
P41 · FY2011 · RR · contact PI
Pharmacogenomics of Membrane Transporters$2,915,001
U19 · FY2010 · GM · contact PI
Cellular Mechanisms of Drug Elimination$329,923
R01 · FY2010 · GM · contact PI
Management$141,192
U19 · FY2010 · GM · contact PI
Project 3$132,455
U54 · FY2010 · GM · contact PI
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS$17,920
P41 · FY2010 · RR · contact PI
Pharmacogenetics of Membrane Transporters$2,834,799
U01 · FY2009 · GM · contact PI
Cellular Mechanisms of Drug Elimination$333,405
R01 · FY2009 · GM · contact PI
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS$23,849
P41 · FY2009 · RR · contact PI
Pharmacogenetics of Membrane Transporters$2,761,679
U01 · FY2008 · GM · contact PI
Cellular Mechanisms of Drug Elimination$333,489
R01 · FY2008 · GM · contact PI
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS$15,238
P41 · FY2008 · RR · contact PI
Pharmacogenetics of Membrane Transporters$2,875,269
U01 · FY2007 · GM · contact PI
Cellular Mechanisms of Drug Elimination$332,637
R01 · FY2007 · GM · contact PI
Pharmacogenetics of Membrane Transporters$105,000
U01 · FY2007 · GM · contact PI
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS$29,093
P41 · FY2007 · RR · contact PI
Pharmacogenetics of Membrane Transporters$2,881,004
U01 · FY2006 · GM · contact PI
CELLULAR MECHANISMS OF DRUG ELIMINATION$323,216
R01 · FY2006 · GM · contact PI
CELLULAR MECHANISMS OF DRUG ELIMINATION$27,035
R01 · FY2006 · GM · contact PI
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS$22,067
P41 · FY2006 · RR · contact PI
Pharmacogenetics of Membrane Transporters$2,949,087
U01 · FY2005 · GM
CELLULAR MECHANISMS OF DRUG ELIMINATION$330,994
R01 · FY2005 · GM
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE TRANSPORTERS$22,570
P41 · FY2005 · RR
IMPACT OF GENETICS ON METFORMIN PHARMACOKINETICS$12,159
M01 · FY2005 · RR
EFFECT OF GENETIC VARIATION IN OAT1 ON THE RENAL SECRETION OF ADEFOVIR$10,276
M01 · FY2005 · RR
GENETIC VARIATION IN THE LIVER TRANSPORTER, OCT1, ON RESPONSE TO METFORMIN$10,113
M01 · FY2005 · RR
EFFECT OF GENETIC VARIATION IN OAT3 ON THE RENAL SECRETION OF CEFOTAXIME$8,808
M01 · FY2005 · RR
IMPACT OF GENETICS ON METFORMIN PHARMACOKINETICS$1,957
M01 · FY2005 · RR
GENETIC BASIS FOR VARIATION IN THE RENAL ELIMINATION OF METFORMIN$489
M01 · FY2005 · RR
STUDY OF PHARMCOGENETICS OF ETHNICALLY DIVERSE POPULATIONS, SOPHIE$163
M01 · FY2005 · RR
PHARMACOGENETICS OF MEMBRANE TRANSPORTERS$2,722,408
U01 · FY2004 · GM
CELLULAR MECHANISMS OF DRUG ELIMINATION$330,994
R01 · FY2004 · GM
AUTOMATED DETECTION OF REGIONS OF INTEREST IN MEMBRANE$22,158
P41 · FY2004 · RR
Impact of Genetics on Metformin Pharmacokinetics$19,166
M01 · FY2004 · RR
Pharmacogenetics of membrane transporters$3,488
M01 · FY2004 · RR
Genetic basis for variation in the renal elimination of metformin$476
M01 · FY2004 · RR
PHARMACOGENETICS OF MEMBRANE TRANSPORTERS$2,643,115
U01 · FY2003 · GM
CELLULAR MECHANISMS OF DRUG ELIMINATION$327,497
R01 · FY2003 · GM
PHARMACOGENETICS OF MEMBRANE TRANSPORTERS$3,072,649
U01 · FY2002 · GM
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS$170,260
R01 · FY2002 · GM
CORE--GENOMICS$131,864
U01 · FY2002 · GM
PHARMACOGENETICS OF MEMBRANE TRANSPORTERS$3,034,266
U01 · FY2001 · GM
CELLULAR MECHANISMS OF DRUG ELIMINATION$188,988
R01 · FY2001 · GM
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS$166,779
R01 · FY2001 · GM
PHARMACOGENETICS OF MEMBRANE TRANSPORTERS$147,500
U01 · FY2001 · GM
CORE--GENOMICS$131,864
U01 · FY2001 · GM
CORE--GENOMICS$0
U01 · FY2001 · GM
PHARMACOGENETICS OF MEMBRANE TRANSPORTERS$3,145,199
U01 · FY2000 · GM
CELLULAR MECHANISMS OF DRUG ELIMINATION$186,091
R01 · FY2000 · GM
CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS$163,399
R01 · FY2000 · GM
MOLECULAR BASIS OF DRUG TRANSPORT IN THE INTESTINE$129,758
R01 · FY2000 · GM
DEVELOPMENT OF TRANSPORT SYSTEMS IN THE CHOROID PLEXUS$22,067
R01 · FY2000 · GM
CORE--GENOMICS$0
U01 · FY2000 · GM